Go Pro
→ They're not buying gold. They're buying this. (From Behind the Markets) (Ad)tc pixel Free COCO Stock Alerts

Vita Coco (COCO) Financials

Vita Coco logo
$55.13 +0.05 (+0.09%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Vita Coco

Annual Income Statements for Vita Coco

This table shows Vita Coco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 9.42 33 19 7.81 47 56 73
Consolidated Net Income / (Loss)		 9.42 33 19 7.81 47 56 71
Net Income / (Loss) Continuing Operations		 9.42 33 19 7.81 47 56 71
Total Pre-Tax Income 		11 44 24 11 58 71 93
Total Operating Income		 13 47 25 3.06 56 74 83
Total Gross Profit		 93 105 113 103 181 199 223
Total Revenue		 284 311 380 428 494 516 610
Operating Revenue		 284 311 380 428 494 516 610
Total Cost of Revenue		 191 206 266 324 313 317 387
Operating Cost of Revenue		 191 206 266 324 313 317 387
Total Operating Expenses		 80 58 89 100 124 125 140
Selling, General & Admin Expense		 79 74 89 100 124 125 140
Total Other Income / (Expense), net		 -1.97 -3.26 -0.36 7.79 1.43 -3.03 10
Interest & Investment Income		 0.23 0.40 0.13 0.05 2.55 6.72 6.55
Other Income / (Expense), net		 -1.03 -2.87 0.01 7.99 -1.12 -9.75 3.89
Income Tax Expense		 1.98 11 5.24 3.03 11 15 22
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - -0.35 0.21 -1.35
Basic Earnings per Share		 $0.17 $0.56 $0.35 $0.14 $0.83 $0.99 $1.25
Weighted Average Basic Shares Outstanding		 56.97M 58.50M 53.69M 55.73M 56.43M 56.73M 56.91M
Diluted Earnings per Share		 $0.16 $0.56 $0.35 $0.14 $0.79 $0.94 $1.19
Weighted Average Diluted Shares Outstanding		 57.15M 58.61M 54.19M 56.12M 58.75M 59.29M 59.97M
Weighted Average Basic & Diluted Shares Outstanding		 - - 55.56M 56.05M 56.93M 56.99M 57.08M

Quarterly Income Statements for Vita Coco

This table shows Vita Coco's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.77 14 19 19 3.37 19 24 24 6.87 30 49
Consolidated Net Income / (Loss)		 6.77 14 19 19 3.37 19 23 24 5.53 30 49
Net Income / (Loss) Continuing Operations		 6.77 14 19 19 3.37 19 23 24 5.53 30 49
Total Pre-Tax Income 		7.96 18 26 26 1.65 24 28 31 9.76 37 64
Total Operating Income		 5.42 19 30 21 4.29 19 25 28 10 34 63
Total Gross Profit		 40 47 59 52 41 48 61 69 45 72 105
Total Revenue		 106 112 144 133 127 131 169 182 128 180 216
Operating Revenue		 106 112 144 133 127 131 169 182 128 180 216
Total Cost of Revenue		 66 65 85 81 86 83 107 114 83 108 111
Operating Cost of Revenue		 66 65 85 81 86 83 107 114 83 108 111
Total Operating Expenses		 34 28 29 31 37 29 36 41 34 38 42
Selling, General & Admin Expense		 34 28 29 31 37 29 36 41 34 38 42
Total Other Income / (Expense), net		 2.54 -0.94 -4.47 5.02 -2.63 5.07 3.05 2.76 -0.44 3.86 1.22
Interest & Investment Income		 1.48 1.52 1.63 1.88 1.69 1.52 1.50 1.78 1.75 1.56 2.48
Other Income / (Expense), net		 1.07 -2.47 -6.10 3.14 -4.32 3.55 1.55 0.98 -2.19 2.30 -1.27
Income Tax Expense		 1.19 3.78 6.42 6.36 -1.72 5.48 5.26 6.68 4.23 6.97 15
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - -0.50 -1.19 - - 0.46 0.31
Basic Earnings per Share		 $0.12 $0.25 $0.34 $0.34 $0.06 $0.33 $0.40 $0.42 $0.10 $0.53 $0.86
Weighted Average Basic Shares Outstanding		 56.43M 56.59M 56.71M 56.77M 56.73M 56.99M 56.80M 56.85M 56.91M 57.11M 57.25M
Diluted Earnings per Share		 $0.10 $0.24 $0.32 $0.32 $0.06 $0.31 $0.38 $0.40 $0.10 $0.50 $0.82
Weighted Average Diluted Shares Outstanding		 58.75M 58.75M 59.24M 59.31M 59.29M 59.98M 59.64M 59.88M 59.97M 60.47M 60.64M
Weighted Average Basic & Diluted Shares Outstanding		 56.93M 56.68M 56.78M 56.73M 56.99M 56.73M 56.82M 56.95M 57.08M 57.11M 57.40M

Annual Cash Flow Statements for Vita Coco

This table details how cash moves in and out of Vita Coco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 11 35 -43 -9.06 113 33 32
Net Cash From Operating Activities		 22 33 -16 -11 107 43 47
Net Cash From Continuing Operating Activities		 22 33 -16 -11 107 43 47
Net Income / (Loss) Continuing Operations		 9.42 33 19 7.81 47 56 71
Consolidated Net Income / (Loss)		 9.42 33 19 7.81 47 56 71
Depreciation Expense		 2.08 2.13 2.07 1.90 0.66 0.75 1.07
Amortization Expense		 - 0.00 0.00 1.06 0.00 1.02 0.02
Non-Cash Adjustments To Reconcile Net Income		 3.31 2.37 3.70 17 11 11 14
Changes in Operating Assets and Liabilities, net		 6.95 -3.95 -41 -39 49 -25 -40
Net Cash From Investing Activities		 -1.01 -0.38 -0.56 -0.98 -0.59 -0.97 -8.25
Net Cash From Continuing Investing Activities		 -1.01 -0.38 -0.56 -0.98 -0.59 -0.97 -8.25
Purchase of Property, Plant & Equipment		 -1.01 -0.39 -0.56 -0.98 -0.60 -0.97 -8.15
Acquisitions		 - - - - 0.00 0.00 -0.10
Sale of Property, Plant & Equipment		 0.00 0.02 0.00 0.00 0.01 0.00 0.00
Net Cash From Financing Activities		 -10 2.05 -27 3.03 6.29 -8.30 -7.53
Net Cash From Continuing Financing Activities		 -10 2.05 -27 3.03 6.29 -8.30 -7.53
Repayment of Debt		 -10 -17 -55 -22 -0.02 -0.01 -0.01
Repurchase of Common Equity		 -0.04 -6.94 -50 0.00 -0.77 -12 -11
Other Financing Activities, net		 0.01 0.89 18 3.06 7.09 3.75 3.75
Effect of Exchange Rate Changes		 0.87 0.44 0.04 -0.18 0.39 -0.56 0.83
Cash Interest Paid		 1.13 0.81 0.35 0.22 0.08 0.00 0.00

Quarterly Cash Flow Statements for Vita Coco

This table details how cash moves in and out of Vita Coco's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 38 -9.56 27 7.53 7.97 -11 13 37 -6.83 5.04 77
Net Cash From Operating Activities		 37 -0.27 27 9.33 6.92 -9.80 22 39 -3.90 16 81
Net Cash From Continuing Operating Activities		 37 -0.27 27 9.33 6.92 -9.80 22 39 -3.90 16 81
Net Income / (Loss) Continuing Operations		 6.77 14 19 19 3.37 19 23 24 5.53 30 49
Consolidated Net Income / (Loss)		 6.77 14 19 19 3.37 19 23 24 5.53 30 49
Depreciation Expense		 0.16 0.16 0.18 0.20 0.21 0.20 0.21 0.23 0.44 0.48 0.49
Amortization Expense		 0.32 0.25 0.25 0.26 0.26 0.00 -0.50 0.01 0.01 0.01 0.00
Non-Cash Adjustments To Reconcile Net Income		 2.01 2.64 1.68 1.68 4.54 3.12 3.88 4.16 3.75 4.88 3.45
Changes in Operating Assets and Liabilities, net		 28 -18 5.71 -12 -1.45 -32 -4.69 11 -14 -20 28
Net Cash From Investing Activities		 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.33 -0.46 -0.15
Net Cash From Continuing Investing Activities		 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.33 -0.46 -0.15
Purchase of Property, Plant & Equipment		 -0.07 -0.12 -0.29 -0.44 -0.13 -0.56 -0.95 -3.41 -3.23 -0.46 -0.15
Net Cash From Financing Activities		 0.39 -9.09 0.52 -1.80 2.07 -1.10 -7.98 1.15 0.40 -9.90 -4.00
Net Cash From Continuing Financing Activities		 0.39 -9.09 0.52 -1.80 2.07 -1.10 -7.98 1.15 0.40 -9.90 -4.00
Repurchase of Common Equity		 -0.77 -9.24 - -2.80 - -1.50 -8.55 -0.15 -1.07 -12 -8.50
Other Financing Activities, net		 1.17 0.15 0.53 1.00 2.07 0.40 0.57 1.30 1.46 1.61 4.51
Effect of Exchange Rate Changes		 0.18 -0.08 -0.03 0.44 -0.90 0.40 0.56 -0.13 0.00 -0.20 -0.05

Annual Balance Sheets for Vita Coco

This table presents Vita Coco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 184 197 198 286 362 461
Total Current Assets		 159 173 175 263 341 421
Cash & Equivalents		 72 29 20 133 165 197
Accounts Receivable		 31 47 43 50 63 82
Inventories, net		 32 75 84 51 84 111
Prepaid Expenses		 23 21 22 24 27 30
Other Current Assets		 1.39 1.30 5.14 5.40 2.34 1.43
Plant, Property, & Equipment, net		 2.88 2.47 2.08 2.14 2.35 9.30
Total Noncurrent Assets		 22 22 21 21 19 30
Goodwill		 7.79 7.79 7.79 7.79 7.79 7.79
Noncurrent Deferred & Refundable Income Taxes		 0.00 1.27 4.26 6.75 6.10 6.46
Other Noncurrent Operating Assets		 4.89 4.76 8.72 6.07 4.85 16
Total Liabilities & Shareholders' Equity		 184 197 198 286 362 461
Total Liabilities		 82 74 57 83 104 130
Total Current Liabilities		 56 74 54 83 103 116
Accounts Payable		 16 28 16 22 31 25
Accrued Expenses		 34 42 38 60 66 89
Other Current Liabilities		 5.36 3.20 0.07 1.21 6.90 1.51
Total Noncurrent Liabilities		 26 0.35 2.32 0.66 0.30 13
Other Noncurrent Operating Liabilities		 0.48 0.30 2.29 0.65 0.30 13
Commitments & Contingencies		 0.00 - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 102 123 141 202 259 332
Total Preferred & Common Equity		 102 123 141 202 259 332
Total Common Equity		 102 123 141 202 259 332
Common Stock		 101 135 146 162 175 186
Retained Earnings		 28 47 55 101 157 228
Treasury Stock		 -8.93 -59 -59 -60 -72 -83
Accumulated Other Comprehensive Income / (Loss)		 -0.95 -0.62 -0.99 -0.65 -0.86 0.49

Quarterly Balance Sheets for Vita Coco

This table presents Vita Coco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 208 245 268 289 323 353 384 421 461 488 573
Total Current Assets		 185 224 247 267 301 331 351 387 423 450 535
Cash & Equivalents		 29 48 95 123 150 157 154 167 204 202 279
Accounts Receivable		 63 90 80 58 79 79 77 103 103 121 132
Inventories, net		 64 57 50 57 45 65 88 84 84 86 83
Prepaid Expenses		 22 20 18 26 25 28 31 31 29 37 38
Other Current Assets		 6.67 8.22 4.67 1.77 1.52 2.56 1.58 2.33 2.94 3.59 3.39
Plant, Property, & Equipment, net		 2.36 2.22 2.23 2.20 2.23 2.44 2.71 3.46 7.21 9.28 8.93
Total Noncurrent Assets		 20 20 19 18 20 20 30 31 31 29 29
Goodwill		 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79 7.79
Noncurrent Deferred & Refundable Income Taxes		 4.26 4.26 4.25 6.75 6.75 6.76 6.10 6.10 6.10 6.47 6.47
Other Noncurrent Operating Assets		 8.18 7.64 6.90 2.99 5.65 5.40 16 17 17 15 15
Total Liabilities & Shareholders' Equity		 208 245 268 289 323 353 384 421 461 488 573
Total Liabilities		 58 74 76 79 91 101 106 124 138 136 172
Total Current Liabilities		 56 71 74 79 91 101 93 110 123 123 159
Accounts Payable		 17 19 21 18 21 31 23 26 22 25 31
Accrued Expenses		 39 52 51 59 64 65 68 81 100 97 127
Other Current Liabilities		 0.02 1.09 1.37 1.63 5.97 4.53 3.16 2.80 1.42 0.91 1.12
Total Noncurrent Liabilities		 2.25 2.12 1.84 0.35 0.22 0.32 13 14 14 13 13
Other Noncurrent Operating Liabilities		 2.22 2.11 1.82 0.34 0.21 0.32 13 14 14 13 13
Commitments & Contingencies		 - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 150 172 193 210 232 252 278 297 324 352 401
Total Preferred & Common Equity		 150 172 193 210 232 252 278 297 324 352 401
Total Common Equity		 150 172 193 210 232 252 278 297 324 352 401
Common Stock		 149 153 159 164 167 170 176 179 183 188 196
Retained Earnings		 61 79 94 115 134 153 176 198 222 258 308
Treasury Stock		 -59 -59 -59 -69 -69 -72 -73 -82 -82 -95 -103
Accumulated Other Comprehensive Income / (Loss)		 -0.82 -0.89 -1.31 -0.66 -0.63 0.16 -0.37 0.83 0.55 0.03 -0.29

Annual Metrics And Ratios for Vita Coco

This table displays calculated financial ratios and metrics derived from Vita Coco's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 9.40% 22.17% 12.72% 15.39% 4.54% 18.17%
EBITDA Growth		 0.00% 219.76% -42.18% -47.47% 309.21% 14.87% 32.92%
EBIT Growth		 0.00% 256.49% -44.09% -55.08% 401.18% 15.72% 34.88%
NOPAT Growth		 0.00% 217.91% -45.13% -88.58% 1,965.41% 28.29% 8.51%
Net Income Growth		 0.00% 246.92% -41.90% -58.86% 496.74% 19.99% 27.47%
EPS Growth		 0.00% 250.00% -37.50% -60.00% 464.29% 18.99% 26.60%
Operating Cash Flow Growth		 0.00% 53.10% -148.51% 32.36% 1,079.93% -59.97% 9.97%
Free Cash Flow Firm Growth		 0.00% 0.00% -0.33% -20.57% 498.23% -64.67% -33.16%
Invested Capital Growth		 0.00% 0.00% 71.38% 27.97% -42.21% 34.66% 43.02%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 1.28% 2.95% 4.27% 0.08%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 22.17% 21.76% -9.04% 9.04%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 16.16% 20.07% -9.24% 10.26%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -1.09% 25.28% 1.11% 1.39%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 8.42% 25.87% -5.73% 3.12%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 16.67% 23.44% -4.08% 3.48%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -10.61% 39.24% 38.71% -41.34% -18.65%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 40.95% -43.17% -39.75%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -6.88% -28.46% -1.33% 12.20%
Profitability Metrics		 - - - - - - -
Gross Margin		 32.75% 33.76% 29.81% 24.16% 36.61% 38.52% 36.50%
EBITDA Margin		 5.08% 14.84% 7.03% 3.27% 11.61% 12.76% 14.35%
Operating Margin		 4.71% 15.08% 6.48% 0.71% 11.44% 14.31% 13.53%
EBIT Margin		 4.35% 14.16% 6.48% 2.58% 11.22% 12.42% 14.17%
Profit (Net Income) Margin		 3.32% 10.52% 5.00% 1.83% 9.45% 10.84% 11.70%
Tax Burden Percent		 82.64% 74.97% 78.39% 72.08% 80.51% 79.04% 76.71%
Interest Burden Percent		 92.40% 99.12% 98.52% 98.13% 104.61% 110.48% 107.58%
Effective Tax Rate		 17.36% 25.03% 21.61% 27.92% 19.49% 20.96% 23.29%
Return on Invested Capital (ROIC)		 0.00% 127.34% 25.74% 2.04% 47.64% 71.12% 55.33%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 137.70% 26.49% -21.01% 46.13% 72.73% 50.90%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -63.43% -8.90% 3.87% -20.49% -46.86% -31.17%
Return on Equity (ROE)		 0.00% 63.90% 16.85% 5.91% 27.15% 24.26% 24.16%
Cash Return on Invested Capital (CROIC)		 0.00% -72.66% -26.86% -22.50% 101.15% 41.58% 19.93%
Operating Return on Assets (OROA)		 0.00% 23.92% 12.90% 5.59% 22.91% 19.77% 20.99%
Return on Assets (ROA)		 0.00% 17.78% 9.96% 3.95% 19.29% 17.27% 17.32%
Return on Common Equity (ROCE)		 0.00% 63.86% 16.84% 5.91% 27.15% 24.26% 24.16%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 31.98% 15.42% 5.54% 23.03% 21.62% 0.00%
Net Operating Profit after Tax (NOPAT)		 11 35 19 2.20 45 58 63
NOPAT Margin		 3.89% 11.31% 5.08% 0.51% 9.21% 11.31% 10.38%
Net Nonoperating Expense Percent (NNEP)		 0.00% -10.36% -0.75% 23.05% 1.51% -1.61% 4.43%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 1.56% 22.46% 22.54% 19.10%
Cost of Revenue to Revenue		 67.25% 66.25% 70.19% 75.84% 63.39% 61.48% 63.50%
SG&A Expenses to Revenue		 27.79% 23.95% 23.33% 23.45% 25.17% 24.22% 22.97%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.04% 18.67% 23.33% 23.45% 25.17% 24.22% 22.97%
Earnings before Interest and Taxes (EBIT)		 12 44 25 11 55 64 86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 46 27 14 57 66 88
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 1.69 5.03 5.48 7.19 8.09 9.11
Price to Tangible Book Value (P/TBV)		 0.00 2.02 5.77 5.80 7.48 8.34 9.32
Price to Revenue (P/Rev)		 0.61 0.56 1.63 1.81 2.95 4.06 4.95
Price to Earnings (P/E)		 18.32 5.28 32.61 98.91 31.22 37.42 41.54
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.46% 18.93% 3.07% 1.01% 3.20% 2.67% 2.41%
Enterprise Value to Invested Capital (EV/IC)		 0.00 2.27 6.26 6.23 18.92 20.49 20.95
Enterprise Value to Revenue (EV/Rev)		 0.00 0.40 1.56 1.76 2.68 3.74 4.63
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 2.72 22.18 53.78 23.09 29.30 32.25
Enterprise Value to EBIT (EV/EBIT)		 0.00 2.85 24.05 68.18 23.90 30.11 32.65
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 3.57 30.69 342.10 29.10 33.07 44.57
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 3.76 0.00 0.00 12.35 44.97 59.82
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 13.70 56.56 123.76
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 0.24 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.24 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -0.46 -0.34 -0.18 -0.44 -0.64 -0.61
Leverage Ratio		 0.00 1.80 1.69 1.50 1.41 1.41 1.40
Compound Leverage Factor		 0.00 1.78 1.67 1.47 1.47 1.55 1.50
Debt to Total Capital		 0.00% 19.67% 0.06% 0.03% 0.01% 0.01% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.02% 0.02% 0.02% 0.01% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 19.66% 0.04% 0.02% 0.01% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 80.26% 99.94% 99.97% 99.99% 100.00% 100.00%
Debt to EBITDA		 0.00 0.54 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 -1.02 -1.07 -1.40 -2.31 -2.50 -2.25
Long-Term Debt to EBITDA		 0.00 0.54 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.71 0.00 0.02 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 -1.34 -1.48 -8.89 -2.91 -2.82 -3.11
Long-Term Debt to NOPAT		 0.00 0.71 0.00 0.01 0.00 0.00 0.00
Altman Z-Score		 0.00 4.64 8.28 11.65 14.11 15.53 17.40
Noncontrolling Interest Sharing Ratio		 0.00% 0.08% 0.03% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 0.00 2.86 2.34 3.22 3.18 3.31 3.62
Quick Ratio		 0.00 1.84 1.03 1.16 2.21 2.21 2.39
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -20 -20 -24 97 34 23
Operating Cash Flow to CapEx		 2,157.09% 8,886.13% -2,902.33% -1,113.54% 18,039.56% 4,404.41% 578.89%
Free Cash Flow to Firm to Interest Expense		 0.00 -25.34 -40.88 -93.98 3,114.94 0.00 0.00
Operating Cash Flow to Interest Expense		 18.71 42.13 -32.86 -42.38 3,456.61 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 17.85 41.65 -33.99 -46.19 3,437.45 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 1.69 1.99 2.16 2.04 1.59 1.48
Accounts Receivable Turnover		 0.00 10.18 9.77 9.45 10.57 9.09 8.41
Inventory Turnover		 0.00 6.44 4.96 4.07 4.64 4.72 3.97
Fixed Asset Turnover		 0.00 107.86 141.79 188.08 234.38 230.00 104.69
Accounts Payable Turnover		 0.00 12.99 12.06 14.66 16.58 12.07 13.77
Days Sales Outstanding (DSO)		 0.00 35.84 37.36 38.63 34.55 40.15 43.39
Days Inventory Outstanding (DIO)		 0.00 56.70 73.54 89.71 78.67 77.29 91.95
Days Payable Outstanding (DPO)		 0.00 28.09 30.27 24.89 22.01 30.25 26.50
Cash Conversion Cycle (CCC)		 0.00 64.45 80.63 103.45 91.20 87.20 108.83
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 55 95 121 70 94 135
Invested Capital Turnover		 0.00 11.26 5.07 3.97 5.17 6.29 5.33
Increase / (Decrease) in Invested Capital		 0.00 55 39 26 -51 24 41
Enterprise Value (EV)		 0.00 125 591 753 1,323 1,929 2,822
Market Capitalization		 173 173 620 773 1,456 2,094 3,019
Book Value per Share		 $0.00 $1.75 $2.22 $2.52 $3.57 $4.56 $5.82
Tangible Book Value per Share		 $0.00 $1.46 $1.94 $2.38 $3.43 $4.42 $5.69
Total Capital		 0.00 127 123 141 202 259 332
Total Debt		 0.00 25 0.08 0.05 0.03 0.01 0.00
Total Long-Term Debt		 0.00 25 0.05 0.03 0.01 0.00 0.00
Net Debt		 0.00 -47 -29 -20 -133 -165 -197
Capital Expenditures (CapEx)		 1.01 0.38 0.56 0.98 0.59 0.97 8.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 31 71 101 48 73 108
Debt-free Net Working Capital (DFNWC)		 0.00 103 99 121 180 238 305
Net Working Capital (NWC)		 0.00 103 99 121 180 238 305
Net Nonoperating Expense (NNE)		 1.63 2.44 0.28 -5.61 -1.15 2.40 -8.01
Net Nonoperating Obligations (NNO)		 0.00 -47 -29 -20 -133 -165 -197
Total Depreciation and Amortization (D&A)		 2.08 2.13 2.07 2.96 1.95 1.77 1.09
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 10.07% 18.61% 23.60% 9.69% 14.22% 17.73%
Debt-free Net Working Capital to Revenue		 0.00% 33.31% 26.17% 28.19% 36.54% 46.13% 50.02%
Net Working Capital to Revenue		 0.00% 33.30% 26.16% 28.19% 36.54% 46.13% 50.02%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.35 $0.14 $0.83 $0.99 $1.25
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 53.69M 55.73M 56.43M 56.73M 56.91M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.35 $0.14 $0.79 $0.94 $1.19
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 54.19M 56.12M 58.75M 59.29M 59.97M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 55.56M 56.05M 56.93M 56.99M 57.08M
Normalized Net Operating Profit after Tax (NOPAT)		 11 23 19 2.20 45 58 63
Normalized NOPAT Margin		 3.89% 7.35% 5.08% 0.51% 9.21% 11.31% 10.38%
Pre Tax Income Margin		 4.02% 14.04% 6.38% 2.53% 11.73% 13.72% 15.25%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 10.61 55.61 49.99 42.82 1,786.13 0.00 0.00
NOPAT to Interest Expense		 9.50 44.41 39.18 8.53 1,467.10 0.00 0.00
EBIT Less CapEx to Interest Expense		 9.74 55.14 48.86 39.02 1,766.97 0.00 0.00
NOPAT Less CapEx to Interest Expense		 8.63 43.94 38.04 4.73 1,447.94 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.28% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.39% 21.23% 263.57% 0.00% 1.66% 21.50% 15.80%

Quarterly Metrics And Ratios for Vita Coco

This table displays calculated financial ratios and metrics derived from Vita Coco's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 57,082,173.00 57,112,643.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 57,082,173.00 57,112,643.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.53 0.86
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 15.39% 1.77% 3.20% -3.74% 19.92% 17.21% 17.10% 37.17% 0.39% 37.31% 28.08%
EBITDA Growth		 401.43% 88.45% 8.27% 27.85% -93.91% 39.29% 10.79% 21.74% 610.86% 57.77% 131.99%
EBIT Growth		 334.19% 93.39% 8.54% 29.34% -100.59% 38.52% 11.68% 21.76% 21,163.16% 57.06% 131.99%
NOPAT Growth		 235.70% 184.21% 33.20% -16.78% 89.66% -0.21% -8.96% 41.13% -33.99% 82.79% 137.49%
Net Income Growth		 341.03% 112.35% 6.15% 26.95% -50.24% 32.62% 19.98% 24.68% 64.01% 61.39% 115.87%
EPS Growth		 300.00% 100.00% 3.23% 23.08% -40.00% 29.17% 18.75% 25.00% 66.67% 61.29% 115.79%
Operating Cash Flow Growth		 412.72% -102.83% 61.82% -78.77% -81.37% -3,570.41% -18.98% 318.86% -156.27% 259.18% 271.06%
Free Cash Flow Firm Growth		 286.59% 727.60% 115.44% -64.97% -127.81% -150.40% -143.13% -115.49% -124.28% 104.98% 303.79%
Invested Capital Growth		 -42.21% -31.54% -33.60% -2.37% 34.66% 50.47% 58.57% 25.78% 43.02% 20.92% -5.88%
Revenue Q/Q Growth		 -23.12% 5.23% 29.02% -7.78% -4.22% 2.85% 28.90% 8.03% -29.91% 40.68% 20.24%
EBITDA Q/Q Growth		 -63.18% 142.72% 43.83% -0.53% -98.25% 5,454.48% 12.01% 10.45% -71.02% 330.57% 71.52%
EBIT Q/Q Growth		 -64.65% 154.23% 44.81% -0.61% -100.16% 60,218.42% 16.75% 8.37% -72.31% 348.29% 72.44%
NOPAT Q/Q Growth		 -75.21% 224.91% 49.76% -31.02% -43.50% 70.96% 36.62% 6.94% -73.57% 373.37% 77.50%
Net Income Q/Q Growth		 -55.34% 110.22% 34.10% 0.83% -82.49% 460.30% 21.32% 4.78% -76.97% 451.37% 62.27%
EPS Q/Q Growth		 -61.54% 140.00% 33.33% 0.00% -81.25% 416.67% 22.58% 5.26% -75.00% 400.00% 64.00%
Operating Cash Flow Q/Q Growth		 -15.43% -100.72% 10,182.02% -65.36% -25.77% -241.58% 322.55% 79.09% -109.97% 500.51% 418.78%
Free Cash Flow Firm Q/Q Growth		 9.61% -4.78% 20.47% -72.14% -187.02% -72.57% -3.09% 89.99% -1,159.83% 103.83% 4,117.98%
Invested Capital Q/Q Growth		 -28.46% 18.09% -0.80% 16.49% -1.33% 31.97% 4.54% -7.60% 12.20% 11.58% -18.63%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 37.50% 42.24% 40.76% 38.80% 32.45% 36.73% 36.30% 37.66% 34.88% 39.95% 48.72%
EBITDA Margin		 6.56% 15.14% 16.87% 18.20% 0.33% 17.99% 15.63% 15.98% 6.61% 20.23% 28.85%
Operating Margin		 5.11% 16.97% 20.80% 15.50% 3.37% 14.74% 14.89% 15.32% 7.98% 18.68% 29.21%
EBIT Margin		 6.11% 14.76% 16.57% 17.86% -0.03% 17.45% 15.80% 15.85% 6.26% 19.96% 28.63%
Profit (Net Income) Margin		 6.38% 12.75% 13.25% 14.48% 2.65% 14.42% 13.57% 13.17% 4.33% 16.95% 22.88%
Tax Burden Percent		 85.06% 79.03% 74.85% 75.16% 204.12% 77.50% 81.32% 78.24% 56.64% 81.39% 76.84%
Interest Burden Percent		 122.75% 109.23% 106.81% 107.90% -4,344.74% 106.64% 105.62% 106.14% 121.91% 104.35% 104.01%
Effective Tax Rate		 14.94% 20.97% 25.15% 24.84% -104.12% 22.50% 18.68% 21.76% 43.36% 18.61% 23.16%
Return on Invested Capital (ROIC)		 22.46% 65.43% 75.85% 59.67% 43.22% 59.11% 63.99% 67.77% 24.08% 72.96% 125.68%
ROIC Less NNEP Spread (ROIC-NNEP)		 19.63% 66.38% 79.22% 56.67% 46.83% 56.31% 62.43% 66.58% 24.22% 71.19% 125.26%
Return on Net Nonoperating Assets (RNNOA)		 -8.72% -28.85% -38.95% -32.06% -30.17% -32.42% -37.43% -41.67% -14.83% -40.17% -80.00%
Return on Equity (ROE)		 13.74% 36.58% 36.90% 27.62% 13.04% 26.69% 26.56% 26.11% 9.25% 32.79% 45.68%
Cash Return on Invested Capital (CROIC)		 101.15% 91.82% 99.73% 62.14% 41.58% 16.02% 7.51% 35.13% 19.93% 36.21% 88.36%
Operating Return on Assets (OROA)		 12.48% 29.47% 29.15% 28.44% -0.05% 27.75% 23.78% 23.72% 9.28% 30.14% 40.66%
Return on Assets (ROA)		 13.03% 25.44% 23.31% 23.06% 4.22% 22.94% 20.43% 19.70% 6.41% 25.60% 32.50%
Return on Common Equity (ROCE)		 13.74% 36.58% 36.90% 27.62% 13.04% 26.69% 26.56% 26.11% 9.25% 32.79% 45.68%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 25.83% 23.82% 23.54% 0.00% 21.81% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 4.61 15 22 15 8.75 15 20 22 5.77 27 49
NOPAT Margin		 4.34% 13.41% 15.57% 11.65% 6.87% 11.42% 12.11% 11.98% 4.52% 15.20% 22.44%
Net Nonoperating Expense Percent (NNEP)		 2.83% -0.96% -3.37% 3.00% -3.62% 2.80% 1.56% 1.20% -0.14% 1.77% 0.42%
Return On Investment Capital (ROIC_SIMPLE)		 2.28% - - - 3.38% 5.38% 6.88% 6.75% 1.74% 7.76% 12.10%
Cost of Revenue to Revenue		 62.50% 57.76% 59.24% 61.20% 67.55% 63.27% 63.70% 62.34% 65.12% 60.05% 51.28%
SG&A Expenses to Revenue		 32.39% 25.26% 19.95% 23.30% 29.08% 21.99% 21.42% 22.35% 26.91% 21.27% 19.51%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 32.39% 25.26% 19.95% 23.30% 29.08% 21.99% 21.42% 22.35% 26.91% 21.27% 19.51%
Earnings before Interest and Taxes (EBIT)		 6.49 16 24 24 -0.04 23 27 29 8.00 36 62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 6.97 17 24 24 0.42 24 26 29 8.45 36 62
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.19 6.63 6.80 6.38 8.09 6.29 6.90 7.45 9.11 7.77 9.42
Price to Tangible Book Value (P/TBV)		 7.48 6.89 7.04 6.58 8.34 6.47 7.08 7.64 9.32 7.94 9.61
Price to Revenue (P/Rev)		 2.95 2.81 3.16 3.25 4.06 3.26 3.66 3.96 4.95 4.15 5.35
Price to Earnings (P/E)		 31.22 25.68 28.56 27.08 37.42 28.82 31.80 34.89 41.54 32.83 34.87
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.20% 3.89% 3.50% 3.69% 2.67% 3.47% 3.14% 2.87% 2.41% 3.05% 2.87%
Enterprise Value to Invested Capital (EV/IC)		 18.92 15.35 17.44 15.20 20.49 12.82 14.48 18.41 20.95 16.86 28.62
Enterprise Value to Revenue (EV/Rev)		 2.68 2.56 2.86 2.93 3.74 2.98 3.36 3.63 4.63 3.85 4.96
Enterprise Value to EBITDA (EV/EBITDA)		 23.09 19.43 21.29 20.04 29.30 21.98 25.06 27.53 32.25 25.12 25.67
Enterprise Value to EBIT (EV/EBIT)		 23.90 20.02 21.91 20.55 30.11 22.62 25.69 28.19 32.65 25.47 25.98
Enterprise Value to NOPAT (EV/NOPAT)		 29.10 22.95 23.45 25.14 33.07 27.35 33.63 35.38 44.57 33.46 33.72
Enterprise Value to Operating Cash Flow (EV/OCF)		 12.35 13.01 13.26 19.84 44.97 47.74 66.57 38.10 59.82 34.90 26.57
Enterprise Value to Free Cash Flow (EV/FCFF)		 13.70 13.59 13.96 24.17 56.56 96.13 236.63 58.39 123.76 50.97 31.41
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.44 -0.43 -0.49 -0.57 -0.64 -0.58 -0.60 -0.63 -0.61 -0.56 -0.64
Leverage Ratio		 1.41 1.38 1.41 1.40 1.41 1.38 1.41 1.41 1.40 1.38 1.42
Compound Leverage Factor		 1.73 1.51 1.50 1.51 -61.04 1.47 1.49 1.50 1.70 1.44 1.48
Debt to Total Capital		 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.99% 99.99% 99.99% 99.99% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -2.31 -1.88 -2.24 -2.16 -2.50 -2.12 -2.23 -2.54 -2.25 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -2.91 -2.23 -2.46 -2.72 -2.82 -2.64 -2.99 -3.26 -3.11 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 13.55 13.76 13.56 12.56 14.95 12.91 12.89 13.51 16.84 15.18 16.30
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.18 3.38 3.31 3.28 3.31 3.76 3.51 3.43 3.62 3.65 3.36
Quick Ratio		 2.21 2.29 2.52 2.34 2.21 2.47 2.45 2.49 2.39 2.62 2.58
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 56 53 64 18 -15 -27 -28 -2.76 -35 1.33 56
Operating Cash Flow to CapEx		 56,290.91% -215.32% 9,282.41% 2,143.68% 5,537.60% -1,753.13% 2,298.21% 1,144.42% -120.66% 3,383.95% 53,595.36%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.04 2.00 1.76 1.59 1.59 1.59 1.50 1.50 1.48 1.51 1.42
Accounts Receivable Turnover		 10.57 8.19 5.94 6.26 9.09 7.95 6.17 6.70 8.41 6.67 6.01
Inventory Turnover		 4.64 4.98 5.81 5.16 4.72 4.63 5.52 5.22 3.97 4.72 4.98
Fixed Asset Turnover		 234.38 217.68 224.53 212.16 230.00 218.24 196.72 126.32 104.69 109.90 113.95
Accounts Payable Turnover		 16.58 17.38 15.21 11.30 12.07 16.46 15.39 14.57 13.77 17.38 14.63
Days Sales Outstanding (DSO)		 34.55 44.59 61.49 58.33 40.15 45.91 59.14 54.51 43.39 54.75 60.71
Days Inventory Outstanding (DIO)		 78.67 73.26 62.82 70.70 77.29 78.92 66.11 69.88 91.95 77.35 73.33
Days Payable Outstanding (DPO)		 22.01 21.01 24.00 32.30 30.25 22.17 23.72 25.04 26.50 21.00 24.94
Cash Conversion Cycle (CCC)		 91.20 96.84 100.31 96.74 87.20 102.66 101.54 99.35 108.83 111.11 109.10
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 70 83 82 95 94 124 130 120 135 150 122
Invested Capital Turnover		 5.17 4.88 4.87 5.12 6.29 5.18 5.29 5.66 5.33 4.80 5.60
Increase / (Decrease) in Invested Capital		 -51 -38 -41 -2.32 24 42 48 25 41 26 -7.64
Enterprise Value (EV)		 1,323 1,268 1,429 1,451 1,929 1,593 1,881 2,210 2,822 2,533 3,499
Market Capitalization		 1,456 1,391 1,579 1,608 2,094 1,747 2,048 2,413 3,019 2,735 3,777
Book Value per Share		 $3.57 $3.68 $4.09 $4.44 $4.56 $4.88 $5.23 $5.70 $5.82 $6.17 $7.02
Tangible Book Value per Share		 $3.43 $3.55 $3.96 $4.30 $4.42 $4.74 $5.10 $5.56 $5.69 $6.03 $6.88
Total Capital		 202 210 232 252 259 278 297 324 332 352 401
Total Debt		 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total Long-Term Debt		 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -133 -123 -150 -157 -165 -154 -167 -204 -197 -202 -279
Capital Expenditures (CapEx)		 0.07 0.12 0.29 0.44 0.13 0.56 0.95 3.41 3.23 0.46 0.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 48 65 60 73 73 105 110 96 108 125 97
Debt-free Net Working Capital (DFNWC)		 180 188 210 230 238 258 277 300 305 326 376
Net Working Capital (NWC)		 180 188 210 230 238 258 277 300 305 326 376
Net Nonoperating Expense (NNE)		 -2.16 0.75 3.35 -3.77 5.38 -3.93 -2.48 -2.16 0.25 -3.14 -0.94
Net Nonoperating Obligations (NNO)		 -133 -127 -150 -157 -165 -154 -167 -204 -197 -202 -279
Total Depreciation and Amortization (D&A)		 0.48 0.42 0.44 0.45 0.46 0.71 -0.29 0.23 0.44 0.48 0.49
Debt-free, Cash-free Net Working Capital to Revenue		 9.69% 13.06% 11.94% 14.82% 14.22% 19.53% 19.59% 15.78% 17.73% 18.92% 13.73%
Debt-free Net Working Capital to Revenue		 36.54% 37.88% 41.96% 46.49% 46.13% 48.23% 49.42% 49.22% 50.02% 49.57% 53.20%
Net Working Capital to Revenue		 36.54% 37.88% 41.96% 46.49% 46.13% 48.22% 49.42% 49.22% 50.02% 49.57% 53.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $0.25 $0.34 $0.34 $0.06 $0.33 $0.40 $0.42 $0.10 $0.53 $0.86
Adjusted Weighted Average Basic Shares Outstanding		 56.43M 56.59M 56.71M 56.77M 56.73M 56.99M 56.80M 56.85M 56.91M 57.11M 57.25M
Adjusted Diluted Earnings per Share		 $0.10 $0.24 $0.32 $0.32 $0.06 $0.31 $0.38 $0.40 $0.10 $0.50 $0.82
Adjusted Weighted Average Diluted Shares Outstanding		 58.75M 58.75M 59.24M 59.31M 59.29M 59.98M 59.64M 59.88M 59.97M 60.47M 60.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 56.93M 56.68M 56.78M 56.73M 56.99M 56.73M 56.82M 56.95M 57.08M 57.11M 57.40M
Normalized Net Operating Profit after Tax (NOPAT)		 4.61 15 22 15 3.00 15 20 22 5.77 27 49
Normalized NOPAT Margin		 4.34% 13.41% 15.57% 11.65% 2.36% 11.42% 12.11% 11.98% 4.52% 15.20% 22.44%
Pre Tax Income Margin		 7.50% 16.13% 17.70% 19.27% 1.30% 18.61% 16.69% 16.83% 7.64% 20.83% 29.77%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 1.66% 18.48% 18.11% 21.57% 21.50% 7.09% 19.95% 14.75% 15.80% 25.66% 19.39%

Financials Breakdown Chart

Key Financial Trends

Vita Coco (NASDAQ:COCO) delivered a strong second quarter of 2026, with significant improvement in revenue, profitability and cash generation compared with the same period in 2025. The company’s Q2 revenue rose 28.1% year over year to $216.2 million, while net income attributable to common shareholders more than doubled to $49.1 million from $24.1 million on a restated basis.

Profitability also improved meaningfully. Gross profit increased to $105.3 million, lifting the gross margin to approximately 48.7% from 36.3% in Q2 2025. Operating income nearly doubled to $63.1 million, and the operating margin expanded to about 29.2% from 14.9%. Selling, general and administrative expenses grew 16.7%, slower than revenue growth, indicating operating leverage.

Cash flow was another major strength. Operating cash flow surged to $80.9 million in Q2 2026 from $21.8 million in the year-ago quarter. The company ended the quarter with $278.6 million of cash and equivalents, up from $167.0 million a year earlier and $201.9 million at the end of Q1 2026.

  • Strong revenue momentum: Q2 2026 revenue increased 28.1% year over year and 20.2% sequentially from Q1 2026, reaching a quarterly record within the provided data.
  • Significant margin expansion: Gross margin improved to approximately 48.7% from 36.3% year over year, while operating margin expanded to approximately 29.2% from 14.9%.
  • Rapid earnings growth: Net income attributable to common shareholders rose to $49.1 million from $24.1 million, and diluted EPS increased to $0.82 from $0.38 on a restated comparison.
  • Improved cost discipline: SG&A increased less rapidly than revenue, falling to approximately 19.5% of revenue from 21.4% in Q2 2025.
  • Excellent operating cash flow: Operating cash flow of $80.9 million in Q2 2026 substantially exceeded net income, providing evidence that reported earnings were supported by cash generation.
  • Strengthening liquidity: Cash increased by $76.7 million during Q2, and the company held $278.6 million of cash against only nominal debt. The current ratio was approximately 3.4, indicating substantial short-term financial flexibility.
  • Continued share repurchases: Vita Coco repurchased $8.5 million of common stock in Q2 and $20.0 million during the first half of 2026, which can support EPS and shareholder returns if the shares are bought at attractive prices.
  • Long-term balance sheet growth: Since Q1 2023, total assets have increased from $207.6 million to $572.9 million, while total equity has grown from $149.7 million to $400.9 million.
  • Working capital was a major cash-flow contributor: Changes in operating assets and liabilities provided $27.5 million in Q2 2026, compared with a $4.7 million use of cash in Q2 2025. This boosted cash flow, but investors should determine how much reflects recurring improvements versus timing in receivables, payables and accrued expenses.
  • Restatements complicate historical comparisons: Several 2023-2025 income and cash-flow periods are marked as restated, so investors should rely on the latest filings when assessing multi-year growth and should be cautious when comparing previously reported figures.

The balance sheet remains conservatively financed, with total liabilities of $172.0 million and no meaningful long-term debt. However, accrued expenses increased to $127.3 million from $97.4 million at the end of Q1, while accounts receivable rose to $132.3 million. These movements helped support the quarter’s cash flow but warrant monitoring as the company grows.

Overall, the latest statements show a company with accelerating sales, expanding margins, strong liquidity and substantial operating cash generation. The key questions for investors are whether Q2’s unusually strong profitability and working-capital benefit can be sustained, and whether continued share repurchases create value without reducing the company’s ability to invest in growth.

09/04/26 08:44 PM ETAI Generated. May Contain Errors.

Vita Coco Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Vita Coco's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Vita Coco's net income appears to be on an upward trend, with a most recent value of $71.32 million in 2025, rising from $9.42 million in 2019. The previous period was $55.95 million in 2024. Find out what analysts predict for Vita Coco in the coming months.

Vita Coco's total operating income in 2025 was $82.53 million, based on the following breakdown:
  • Total Gross Profit: $222.60 million
  • Total Operating Expenses: $140.06 million

Over the last 6 years, Vita Coco's total revenue changed from $283.95 million in 2019 to $609.78 million in 2025, a change of 114.7%.

Vita Coco's total liabilities were at $129.62 million at the end of 2025, a 25.2% increase from 2024, and a 58.9% increase since 2020.

In the past 5 years, Vita Coco's cash and equivalents has ranged from $19.63 million in 2022 to $196.87 million in 2025, and is currently $196.87 million as of their latest financial filing in 2025.

Over the last 6 years, Vita Coco's book value per share changed from 0.00 in 2019 to 5.82 in 2025, a change of 582.2%.


Related Companies

Financial statements for NASDAQ:COCO last updated on 7/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Man Who Called SpaceX Rise Says Elon’s NEW Project is Even Bigger
James Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover...
Paradigm Press | Sponsoredtc pixel
Half the market is standing on a trapdoor
Nearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been...
Behind the Markets | Sponsoredtc pixel
Anthropic’s confidential SEC filing — and the public ticker that holds it
Anthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...
The Oxford Club | Sponsoredtc pixel
A New Approach to Retirement Income That Needs Less Capital
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsoredtc pixel
Pass by August 7… or wait until 2027?
I’m making my next major call for what could be one of crypto’s biggest catalysts: The CLARITY Act. The bil...
Crypto 101 Media | Sponsoredtc pixel